This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Cosentyx Alleviates Psoriasis‐Induced Podocyte Injury by Inhibiting the TLR/NF‐κB Signaling Pathway
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPsoriasis: Treatment and Pathogenesis · Therapeutic Uses of Natural Elements · Autoimmune Bullous Skin Diseases
RETRACTION: W. Aixue, W. Feng, Z. Huanhuan, M. Xixing, and L. Yanling, “Cosentyx Alleviates Psoriasis‐Induced Podocyte Injury by Inhibiting the TLR/NF‐κB Signaling Pathway,” Skin Research and Technology 30, no. 2 (2024): e13562, https://doi.org/10.1111/srt.13562.
The above article, published online on 26 January 2024 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between Skin Research and Technology; and John Wiley & Sons Ltd. The article was accepted for publication following an insufficient peer review process that does not meet the standards of the journal's peer review policy. Further investigation by the publisher uncovered concerns regarding compliance with ethical standards for animal experimentation. Accordingly, the article has been retracted. The authors have been informed of this decision.